Eli Lilly CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, the head of the pharma giant says that they are looking to create an oral tablet in addition to an injectable device and hopes to get them to the market quicker.

AMD’s Lisa Su, Fei-Fei Li Discuss $8.2 Billion World Labs Deal
08:35

Former Disney CEO Bob Chapek Talks His Time at Disney
26:37

NEC's Kevin Hassett Talks US Economic Goals
21:45